The CYP17A1 −34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers

By Kaufman Bella  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 521-527

Springer Publishing Company

Access to resources Recommend Favorite

No association between CYP17 T-34C polymorphism and breast cancer risk: a meta-analysis involving 58,814 subjects

By Yao Lei  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 221-227

Springer Publishing Company

Access to resources Recommend Favorite

CYP1A1 exon7 polymorphism is associated with lung cancer risk among the female population and among smokers: a meta-analysis

By Xu Chun-hua   Wang Qin   Qian Qian   Zhan Ping   Yu Li-Ke  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3901-3911

Springer Publishing Company

Access to resources Recommend Favorite

Factors influencing the association between CYP17 T34C polymorphism and the risk of breast cancer: meta-regression and subgroup analysis

By Chen Yun   Pei Jianping  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 471-481

Springer Publishing Company

Access to resources Recommend Favorite

Genetic polymorphisms of CYP17A1 in steroidogenesis pathway are associated with risk of progression to castration-resistant prostate cancer in Japanese men receiving androgen deprivation therapy

By Yamada Takeshi   Nakayama Masashi   Shimizu Tomohito   Nonen Shinpei   Nakai Yasutomo   Nishimura Kazuo   Fujio Yasushi   Okuyama Akihiko   Azuma Junichi   Nonomura Norio  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 711-717

Springer Publishing Company

Access to resources Recommend Favorite